Table 3 Number of significant Type I, II and III perturbagens found in each cancer.

From: Systematic Analysis of Sex-Linked Molecular Alterations and Therapies in Cancer

Cancer

Type I

Type II

Type III

Total Sex-Specific

LIHC

432

207

13

639

LUAD

175

243

134

418

LUSC

214

153

153

367

KIRC

0

312

1

312

HNSC

0

236

33

236

KICH

0

232

0

232

THCA

0

0

3

0

  1. The table summarizes the number of significant perturbagens of each type in each cancer, based on an empirical BH-value threshold of 0.05 and an additional significance threshold magnitude of 90 for Type III drugs only. BH-values were calculated through permutation analysis (see Materials and methods). The “total sex-specific” column indicates the number of sex-specific (that is, Type I and II) perturbagens in each cancer.
Back to article page